Check your coverage first. Part D and commercial plans can cover it for type 2 diabetes, and Novo’s savings offer can bring a covered fill down to $25.

| Way to pay | What you pay | Good to know | Checked |
|---|---|---|---|
| Way to pay NovoCare self-pay Pen | What you pay $199–$499 per month | Good to know New patients pay $199 for the first two fills at 0.25 and 0.5 mg, through December 31, 2026. After that, $349 at 0.25 to 1 mg and $499 at 2 mg. One pen a month. | Checked Sep 25, 2026 Ozempic price guide |
| Way to pay NovoCare self-pay, Ozempic pill Pill | What you pay $149–$299 per month | Good to know 1.5 mg $149, 4 mg $199 and 9 mg $299 for 30 tablets. | Checked Sep 25, 2026 Ozempic price guide |
| Way to pay TrumpRx.gov Pen | What you pay $199–$499 per month | Good to know The same self-pay prices next to a $1,027.51 list price. You show a coupon at a retail pharmacy; self-pay only. | Checked Sep 25, 2026 trumprx.gov |
| Way to pay Commercial plan that covers Ozempic PenPill | What you pay From $25 per month | Good to know Novo’s savings offer caps savings at $100 a month. Government beneficiaries are excluded. | Checked Sep 25, 2026 Ozempic price guide |
| Way to pay Medicare Part D (type 2 diabetes) PenPill | What you pay Plan copay | Good to know Part D plans can cover Ozempic for type 2 diabetes at the plan’s normal copays. From January 1, 2027, Medicare’s negotiated semaglutide price of $274 a month applies to those uses. The $50 GLP-1 Bridge doesn’t cover Ozempic. | Checked Sep 26, 2026 medicare.gov |
| Way to pay Telehealth resellers Pen | What you pay $1,199–$1,399 per month | Good to know Some telehealth sites sell the pen themselves: Wellorithm at $1,199 a month (3 months paid upfront), Gala and Pallas Health at $1,299, Eden and Wellmedr from $1,399. That’s up to four times Novo’s $349 self-pay price. | Checked Oct 1, 2026 our provider data |
| Way to pay List price, no coverage or program | What you pay About $1,028 per month | Good to know $1,027.51 a month before any Novo program, as listed on TrumpRx.gov. | Checked Sep 25, 2026 trumprx.gov |
If you have type 2 diabetes, check your insurance first: Part D and commercial plans can cover Ozempic for diabetes, and Novo’s savings offer can bring a covered fill down to $25. Paying cash, NovoCare’s $349 to $499 a month is far below the $1,199 to $1,399 that some telehealth sites charge for the same pen.
Ozempic is approved for type 2 diabetes. If you have diabetes, your own doctor can prescribe it, and insurance or NovoCare’s self-pay price will cost far less than any provider below. These five telehealth providers list Ozempic and sell the pen themselves, at $1,199 to $1,399 a month, three to four times Novo’s self-pay price. A clinician decides whether it’s right for you. If your goal is weight loss, Wegovy is the same drug approved for it.
Checked: Oct 1, 2026
Checked: Sep 30, 2026
Checked: Sep 30, 2026
Checked: Sep 25, 2026
Checked: Sep 23, 2026
Check your coverage first. Part D and commercial plans can cover it for type 2 diabetes, and Novo’s savings offer can bring a covered fill down to $25.
New to Ozempic? Your first two fills at 0.25 and 0.5 mg cost $199 each at NovoCare through December 31, 2026.
Paying cash? NovoCare charges $349 a month at 0.25 to 1 mg and $499 at 2 mg, a fraction of the $1,199 to $1,399 some telehealth sites charge.
Ask about the Ozempic pill. It’s also approved for type 2 diabetes, and NovoCare sells it for $149 to $299 a month.
On Medicare? From January 1, 2027, Medicare’s negotiated price for semaglutide, $274 a month, applies to Part D coverage for diabetes.
Ozempic is Novo Nordisk’s brand of semaglutide for adults with type 2 diabetes. The once-weekly injection helps lower blood sugar along with diet and exercise. It’s also approved to lower the risk of heart attack, stroke and worsening kidney disease in adults with type 2 diabetes who have heart disease or chronic kidney disease. It is not approved for weight loss.
Treatment starts at 0.25 mg a week for four weeks, then 0.5 mg. If blood sugar needs more control, the dose can rise to 1 mg and then 2 mg, at least four weeks apart. The most common side effects are nausea, vomiting, diarrhea, stomach pain and constipation. Our GLP-1 side effects guide covers what to expect and when to call a doctor.
Wegovy contains the same drug at different doses, and it’s the version approved for weight management: see Wegovy prices. It also comes as a daily tablet for type 2 diabetes. If you’re comparing brand-name semaglutide with a compounded version, read FDA-approved vs. compounded GLP-1s first.

At NovoCare’s self-pay prices, new patients pay $199 for each of their first two fills at 0.25 and 0.5 mg, through December 31, 2026. After that, a pen costs $349 a month at 0.25 to 1 mg and $499 at 2 mg. The list price is about $1,028 a month.
No. It’s FDA-approved for adults with type 2 diabetes, to improve blood sugar control and lower heart and kidney risks. Wegovy contains the same drug and is approved for weight management. Wegovy prices and providers.
Part D plans can cover it for type 2 diabetes at the plan’s usual copay. From January 1, 2027, Medicare’s negotiated price for semaglutide, $274 a month, applies. The $50 Medicare GLP-1 Bridge doesn’t include Ozempic.
Commercial plans can cover it for type 2 diabetes. If yours does, Novo’s savings offer can bring a fill down to $25, with savings capped at $100 a month. People with government insurance can’t use the offer. How GLP-1 coverage works.
They sell the pen themselves, close to its list price. NovoCare sells the same pen for $349 to $499 a month with a prescription from any licensed clinician, so ask where your prescription will be filled before you pay.
Yes. Ozempic tablets are approved for type 2 diabetes, like the injection. NovoCare sells 30 tablets for $149 at 1.5 mg, $199 at 4 mg and $299 at 9 mg.
Both contain semaglutide and both come from Novo Nordisk. Ozempic is approved for type 2 diabetes; Wegovy is approved for weight management and heart risk reduction. Their doses, pens and self-pay prices differ.
It has the same active ingredient, but compounded semaglutide is not FDA-approved, and the FDA doesn’t review compounded drugs for safety, effectiveness or quality before they’re sold. Compounded semaglutide prices.
Looking More GLP-1 Medications?
View the full catalogue of GLP-1 Medications
We read Novo’s Ozempic price guide, TrumpRx.gov and Medicare.gov on September 25 and 26, 2026, the FDA label on DailyMed, and each provider’s own Ozempic pages between September 23 and October 1, 2026. We don’t buy the drug or sign up for plans. Every number comes from a published page, and each card and table row shows when we checked it. We recheck prices every month. If a price has changed, tell us.
Every provider on this page is an affiliate partner, and we earn a commission when you sign up through our links. Commissions never change the order or what we write. How we make money and our editorial policy explain the rules we follow. We drafted this page with AI assistance and checked every number against its source.


